Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of bevacizumab on success of trabeculectomy in glaucoma
IRCT2012120711647N1Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jan 2013
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2 trial of bevacizumab in open-angle glaucoma (OAG), sponsored by Tehran University of Medical Sciences. Started Jan 2013; status: completed.
02
Drugs
bevacizumab
03
Conditions
open-angle glaucoma (OAG)
Beyond the preview
Go deeper on IRCT2012120711647N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2012120711647N1.